← Back to Search

Active Colonoscopy Choice for Colorectal Cancer (CRC45+ Trial)

N/A

Waitlist Available

Research Sponsored by University of California, Los Angeles

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 4 weeks from receiving the initial mychart message

Awards & highlights

No Placebo-Only Group

Summary

This trial tests different ways to remind and encourage people aged 45-49 to get screened for colorectal cancer. It uses text messages and an online health portal to offer choices between different screening methods. The goal is to find the most effective approach to increase participation in cancer screenings.

Eligible Conditions

Colorectal Cancer
Health Screening

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 4 weeks from receiving the initial mychart message

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 4 weeks from receiving the initial mychart message

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 4 weeks from receiving the initial mychart message for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Overall completion of any Colorectal Cancer Screening test

Secondary study objectives

CRC screening order placed by any modality

Colorectal cancer screening uptake by modality

Selection of modality in MyChart Survey

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

4Treatment groups

Experimental Treatment

Active Control

Group I: FIT ChoiceExperimental Treatment1 Intervention

This group will receive a tailored message via MyChart with information about CRC screening and using the FIT kit for noninvasive screening. They will then have to actively choose if they want CRC screening with a FIT kit vs no screening. If they opt for screening, the investigators will mail them a FIT kit.

Group II: Dual ChoiceExperimental Treatment1 Intervention

This group will receive a tailored message via MyChart with information about CRC screening and using either the FIT kit or colonoscopy for CRC screening. They will then have to actively choose if they want CRC screening with a FIT kit, a colonoscopy, or no screening. If they opt for screening, the investigators will either mail them a FIT kit or direct them to our patient navigators to schedule a colonoscopy, depending on their choice.

Group III: Colonoscopy ChoiceExperimental Treatment1 Intervention

This group will receive a tailored message via MyChart with information about CRC screening and colonoscopy for CRC screening. They will then have to actively choose if they want CRC screening with a colonoscopy vs no screening. If they opt for screening, the investigators will direct them to our patient navigators to get scheduled for a colonoscopy.

Group IV: Standard of CareActive Control1 Intervention

No Intervention-"Standard Care" UCLA Health has a mailed FIT outreach program. This group will receive standard FIT mailer protocol. They will receive a tailored MyChart message indicating the importance of CRC screening and not be presented with a choice for screening modalities.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Active FIT Choice

2022

N/A

~20510

Active Dual Choice

2022

N/A

~20510